Drug screening and functional assays revealed that HSP90 controls protein stability of the nuclear transcription factor STAT1 in a variety of different cancer cells, thereby promoting subsequent gene expression of immune checkpoint molecules (IDO1 and PD-L1). The gene discussed is HSP90AA1; the disease is cancer.